El probiótico #1 del mundo para prevenir y tratar trastornos intestinales.*²

Nicholas Hall, 2024

1. Ghelardi et al (2015). Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology 119, 552-559.
2. Vecchione A et al (2018). Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy. Front Med (Lausanne) 5:59.
3. Giua et al (2024). A Prospective Real‑World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study. Drugs - Real World Outcomes (2024) 11:137–147.
4. Acosta et al (2022). Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Adv Ther (2022) 39:4854–4874.
5. Paparo L et al. Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection. Sci Rep. 2020;10:12636.
6. Lahiri K et al. Bacillus clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2015;14:74-76

1. Weiss GA & Hennet T. Cell Mol Life Sci. 2017;74:2959-2977
2. Tarasiuk A & Fichna J. J Expert Rev Clin Pharmacol. 2019;12:921-30
3. Amabebe E, et al. Br J Nutr. 2020;123:1127-1137.
4. Gulas E, et al. Psychiatr Pol. 2018;52:1023-1039.
5. Leeming ER, et al. Nutrients. 2019;11(12):2862.
6. Danis R & Wawruch M. Cent Eur J Public Health. 2022;30:20–25

Referencias para el reto de 7 días (A-D)

A- Lahiri K et al. Bacillus clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2015;14:74-76.

B- Giua et al (2024). A Prospective Real‑World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study. Drugs - Real World Outcomes (2024) 11:137–147.

C- Ghelardi et al (2015). Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. Journal of Applied Microbiology 119, 552-559.

D- Castro et al (2019). Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE). Tropical Diseases, Travel Medicine and Vaccines 5:14.